Bio Financial Statements From 2010 to 2026

BIO Stock  USD 304.91  5.93  1.98%   
Bio Rad's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bio Rad's valuation are provided below:
Gross Profit
1.3 B
Profit Margin
(0.26)
Market Capitalization
8.1 B
Enterprise Value Revenue
3.1264
Revenue
2.6 B
We have found one hundred twenty available fundamental signals for Bio Rad Laboratories, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Bio Rad's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 4th of February 2026, Market Cap is likely to grow to about 919.2 M. Also, Enterprise Value is likely to grow to about 1 B

Bio Rad Total Revenue

3.1 Billion

Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 183.1 M, Interest Expense of 59 M or Selling General Administrative of 492 M, as well as many indicators such as Price To Sales Ratio of 3.41, Dividend Yield of 0.0 or PTB Ratio of 2.12. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
  
Build AI portfolio with Bio Stock
Check out the analysis of Bio Rad Correlation against competitors.

Bio Rad Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets11.3 B10.8 B7.5 B
Slightly volatile
Short and Long Term Debt Total1.7 B1.6 B742.2 M
Slightly volatile
Other Current Liabilities195.6 M312.1 M269.6 M
Slightly volatile
Total Current Liabilities343.3 M538 M495 M
Slightly volatile
Total Stockholder Equity7.9 B7.6 B5.3 B
Slightly volatile
Property Plant And Equipment Net831.5 M791.9 M551.7 M
Slightly volatile
Retained EarningsB8.5 B5.2 B
Slightly volatile
Cash589.4 M561.3 M458.1 M
Slightly volatile
Non Current Assets Total7.6 B7.3 B5.2 B
Slightly volatile
Non Currrent Assets Other65 M117.2 M80.4 M
Pretty Stable
Cash And Short Term InvestmentsB1.9 B1.1 B
Slightly volatile
Net Receivables278 M520.4 M394.8 M
Slightly volatile
Common Stock Shares Outstanding29 M32.4 M29 M
Slightly volatile
Liabilities And Stockholders Equity11.3 B10.8 B7.5 B
Slightly volatile
Non Current Liabilities Total2.8 B2.7 B1.7 B
Slightly volatile
Inventory917.7 M874 M581.8 M
Slightly volatile
Other Current Assets94.8 M176.3 M140 M
Pretty Stable
Total Liabilities3.4 B3.2 B2.2 B
Slightly volatile
Property Plant And Equipment Gross2.2 B2.1 B973.2 M
Slightly volatile
Total Current Assets3.7 B3.5 B2.2 B
Slightly volatile
Short Term Debt35.2 M49.3 M44.5 M
Pretty Stable
Accounts Payable92.2 M140.6 M122.9 M
Slightly volatile
Intangible Assets194.2 M337.6 M225.2 M
Slightly volatile
Common Stock Total Equity2.6 K2.7 K738 K
Slightly volatile
Common Stock2.6 K2.7 K738.1 K
Slightly volatile
Long Term Debt1.4 B1.4 B632 M
Slightly volatile
Good Will343.6 M472.1 M395.4 M
Very volatile
Property Plant Equipment404.3 M791.9 M498 M
Slightly volatile
Current Deferred Revenue43.2 B41.1 B9.2 B
Slightly volatile
Other Liabilities2.4 B2.3 B1.2 B
Slightly volatile
Short Term Investments1.4 B1.4 B619.4 M
Slightly volatile
Net Tangible Assets11.1 B10.6 B5.8 B
Slightly volatile
Capital Surpluse385.8 M532.7 M355.4 M
Slightly volatile
Non Current Liabilities Other218 M203.8 M194.4 M
Slightly volatile
Deferred Long Term Asset Charges15.6 M17.8 M15.5 M
Slightly volatile
Long Term Debt Total1.4 B1.4 B663.3 M
Slightly volatile
Long Term Investments5.1 B5.6 BB
Slightly volatile
Short and Long Term DebtM1.1 M179.3 M
Slightly volatile
Cash And Equivalents536.7 M561.3 M483.9 M
Slightly volatile
Net Invested Capital7.2 B8.9 B5.4 B
Slightly volatile
Net Working CapitalB2.9 B1.8 B
Slightly volatile
Capital Lease Obligations160.6 M155.8 M201.4 M
Slightly volatile

Bio Rad Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization183.1 M174.3 M140.9 M
Slightly volatile
Selling General Administrative492 M936.1 M745.6 M
Slightly volatile
Total Revenue3.1 BB2.3 B
Slightly volatile
Gross Profit1.7 B1.6 B1.3 B
Slightly volatile
Other Operating Expenses2.8 B2.6 BB
Slightly volatile
Cost Of Revenue1.4 B1.4 BB
Slightly volatile
Total Operating Expenses1.3 B1.3 BB
Slightly volatile
Research Development357.3 M340.3 M228.8 M
Slightly volatile
Minority Interest18 K18.9 K101.6 K
Slightly volatile
Non Operating Income Net Other54.1 M51.5 M23.8 M
Slightly volatile
Non Recurring353.2 M336.4 M187.3 M
Slightly volatile
Interest Income89.6 M94.3 M590.9 M
Pretty Stable
Reconciled Depreciation154.8 M174.3 M146.8 M
Pretty Stable
Extraordinary Items47.6 M44.1 M58.5 M
Slightly volatile
Selling And Marketing Expenses1.2 M1.3 M1.5 M
Slightly volatile

Bio Rad Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow276.1 M465.1 M459.4 M
Very volatile
Depreciation183.1 M174.3 M136.3 M
Slightly volatile
Capital Expenditures228.2 M217.3 M131.7 M
Slightly volatile
Total Cash From Operating Activities549.7 M523.5 M327.7 M
Slightly volatile
End Period Cash Flow290.9 M563.3 M441.4 M
Slightly volatile
Change Receivables82.3 M78.4 M34.7 M
Slightly volatile
Cash Flows Other Operating137.9 M145.2 M247.8 M
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.413.253.2623
Slightly volatile
PTB Ratio2.121.621.7828
Slightly volatile
Days Sales Outstanding86.8974.0168.6906
Pretty Stable
Book Value Per Share220210174
Slightly volatile
Operating Cash Flow Per Share15.2514.5210.8301
Slightly volatile
Stock Based Compensation To Revenue0.02290.02180.0137
Slightly volatile
Capex To Depreciation1.41.431.0198
Pretty Stable
PB Ratio2.121.621.7828
Slightly volatile
EV To Sales3.743.563.3739
Slightly volatile
Inventory Turnover2.181.81.8831
Slightly volatile
Days Of Inventory On Hand150210195
Slightly volatile
Payables Turnover5.748.747.8119
Slightly volatile
Sales General And Administrative To Revenue0.430.420.377
Pretty Stable
Research And Ddevelopement To Revenue0.07620.10.095
Very volatile
Capex To Revenue0.07010.08470.0578
Pretty Stable
Cash Per Share55.7553.135.2557
Slightly volatile
POCF Ratio15.218.3325.7224
Slightly volatile
Capex To Operating Cash Flow0.450.480.5419
Slightly volatile
Days Payables Outstanding58.4243.2347.7795
Slightly volatile
EV To Operating Cash Flow17.4620.0826.9516
Slightly volatile
Intangibles To Total Assets0.150.08650.1246
Slightly volatile
Current Ratio6.125.834.2712
Slightly volatile
Tangible Book Value Per Share196187153
Slightly volatile
Receivables Turnover3.795.15.3745
Pretty Stable
Shareholders Equity Per Share220210174
Slightly volatile
Debt To Equity0.230.240.2208
Slightly volatile
Capex Per Share6.336.034.3815
Slightly volatile
Revenue Per Share85.9681.8776.2636
Slightly volatile
Interest Debt Per Share47.6845.4125.4232
Slightly volatile
Debt To Assets0.240.170.1384
Slightly volatile
Graham Number1.1 K1.1 K549
Slightly volatile
Short Term Coverage Ratios358341457
Pretty Stable
Operating Cycle293343271
Slightly volatile
Price Book Value Ratio2.121.621.7828
Slightly volatile
Days Of Payables Outstanding58.4243.2347.7795
Slightly volatile
Price To Operating Cash Flows Ratio15.218.3325.7224
Slightly volatile
Company Equity Multiplier2.171.641.579
Slightly volatile
Long Term Debt To Capitalization0.280.180.1538
Slightly volatile
Total Debt To Capitalization0.320.20.1746
Slightly volatile
Debt Equity Ratio0.230.240.2208
Slightly volatile
Quick Ratio4.594.373.1286
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.742.172.3778
Slightly volatile
Net Income Per E B T0.580.710.7553
Very volatile
Cash Ratio0.990.940.8701
Pretty Stable
Cash Conversion Cycle240299227
Slightly volatile
Operating Cash Flow Sales Ratio0.0880.160.1273
Slightly volatile
Days Of Inventory Outstanding150210195
Slightly volatile
Days Of Sales Outstanding86.8974.0168.6906
Pretty Stable
Cash Flow Coverage Ratios0.480.30.6778
Pretty Stable
Price To Book Ratio2.121.621.7828
Slightly volatile
Fixed Asset Turnover5.54.294.6254
Slightly volatile
Capital Expenditure Coverage Ratio1.742.172.3778
Slightly volatile
Price Cash Flow Ratio15.218.3325.7224
Slightly volatile
Debt Ratio0.240.170.1384
Slightly volatile
Cash Flow To Debt Ratio0.480.30.6778
Pretty Stable
Price Sales Ratio3.413.253.2623
Slightly volatile
Asset Turnover0.30.320.4673
Slightly volatile
Gross Profit Margin0.630.620.5599
Slightly volatile
Price Fair Value2.121.621.7828
Slightly volatile

Bio Rad Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap919.2 M875.4 M914 M
Slightly volatile
Enterprise ValueB952.4 M995.4 M
Slightly volatile

Bio Fundamental Market Drivers

Forward Price Earnings30.7692
Cash And Short Term Investments1.7 B

Bio Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bio Rad Financial Statements

Bio Rad investors utilize fundamental indicators, such as revenue or net income, to predict how Bio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue41.1 B43.2 B
Total RevenueB3.1 B
Cost Of Revenue1.4 B1.4 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.42  0.43 
Research And Ddevelopement To Revenue 0.10  0.08 
Capex To Revenue 0.08  0.07 
Revenue Per Share 81.87  85.96 
Ebit Per Revenue 0.09  0.08 

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bio Stock

  0.85A Agilent Technologies Earnings Call TodayPairCorr

Moving against Bio Stock

  0.37YLLXF Yellow Cake plc Upward RallyPairCorr
  0.33SLF Sun Life Financial Earnings Call This WeekPairCorr
  0.32APETF Alpha Esports TechPairCorr
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out the analysis of Bio Rad Correlation against competitors.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Will Life Sciences Tools & Services sector continue expanding? Could Bio diversify its offerings? Factors like these will boost the valuation of Bio Rad. Projected growth potential of Bio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bio Rad data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.83)
Earnings Share
(24.01)
Revenue Per Share
92.937
Quarterly Revenue Growth
0.005
Return On Assets
0.0157
Bio Rad Laboratories's market price often diverges from its book value, the accounting figure shown on Bio's balance sheet. Smart investors calculate Bio Rad's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bio Rad's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bio Rad's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bio Rad should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.